Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203.1 USD | -3.29% | -1.07% | -19.26% |
May. 08 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
May. 07 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.26% | 7.87B | |
+73.50% | 12.41B | |
+2.40% | 6.37B | |
+3.66% | 5.81B | |
+11.89% | 5.36B | |
+37.45% | 4.92B | |
-19.73% | 4.02B | |
-35.58% | 2.43B | |
+0.74% | 2.02B | |
+9.36% | 1.97B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01